Paul Blackburn, RN, MNA, VA- BC, Joins RyMed Technologies as Senior Director of Marketing and Clinical Education
FRANKLIN, Tenn., Feb. 13, 2012 /PRNewswire/ — RyMed Technologies Inc. (www.rymedtech.com) is proud to announce that renowned and industry-respected RN, Paul Blackburn has joined RyMed as Senior Director, Marketing and Clinical Education. Prior to RyMed, Blackburn was Director of Clinical Education, Clinical Programs and Marketing for Bard-Access Systems, division of CR Bard, Inc.
“Paul brings to RyMed not only a wealth of knowledge and experience, but also the reputation across the United States as one of the leading experts in IV Therapy. Between Paul’s experience and the InVision-Plus’® unique technology, we fully expect to continue our growth within this competitive marketplace,” said Dana Wm. Ryan, President & CEO, RyMed Technologies, Inc.
“More importantly, I think Paul will also help RyMed advance its efforts in working with hospitals to significantly reduce the pain and suffering of the patient and their family members by lowering Catheter-Related Bloodstream Infections and Thrombotic Occlusions,” added Ryan.
Blackburn has more than twenty years of managerial and teaching experience in healthcare, having managed 150 clinical educators and growing a peripherally inserted central catheter market from $30 million annually to over $295 million annually. Blackburn’s accomplishments in the vascular access industry and knowledge in clinical and sales education, marketing, training programs lends important credibility to RyMed’s innovations.
“RyMed Technologies developed the zero displacement Needleless IV Connector in response to a need expressed by professionals involved in the science of vascular access. Since its launch, the InVision Plus® has been refined to meet the ever changing needs of this specialty practice,” said Paul Blackburn.
“Even more exciting is that RyMed is on the verge of launching a new product that once again is aligned with the needs of this specialty practice. I look forward to working with the team as we bring the InVision-Plus® CS® with Chlorhexidine + Silver Ion technology to market. I am passionate about the science of vascular access, working with professionals who are dedicated to making healthcare delivery safer, more cost effective and improving patient outcomes,” added Blackburn.
About RyMed Technologies, Inc.
Founded in 1994, RyMed Technologies specializes in the development and marketing of innovative safety products in the field of intravenous catheter care management. The company’s products are designed to help reduce catheter-related bloodstream infections (CR-BSIs) and intraluminal thrombotic catheter occlusions associated with needleless IV connectors. More than 10 years of research and development have gone into InVision-Plus® IV Connector. For more information, call (615) 790-8093 or access www.rymedtech.com.
CONTACT: Glen Calder, (561) 750-9800 ext. 216, firstname.lastname@example.org
SOURCE RyMed Technologies, Inc.